These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626 [TBL] [Abstract][Full Text] [Related]
33. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor. Talka R; Salminen O; Tuominen RK Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810 [TBL] [Abstract][Full Text] [Related]
34. Neonicotinic analogues: selective antagonists for α4β2 nicotinic acetylcholine receptors. Faundez-Parraguez M; Farias-Rabelo N; Gonzalez-Gutierrez JP; Etcheverry-Berrios A; Alzate-Morales J; Adasme-Carreño F; Varas R; Bermudez I; Iturriaga-Vasquez P Bioorg Med Chem; 2013 May; 21(10):2687-94. PubMed ID: 23561269 [TBL] [Abstract][Full Text] [Related]
35. U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line. Zheng C; Wang MY; Liu Q; Wakui M; Whiteaker P; Lukas RJ; Wu J J Neurochem; 2009 Mar; 108(6):1526-38. PubMed ID: 19183258 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists. Crestey F; Jensen AA; Borch M; Andreasen JT; Andersen J; Balle T; Kristensen JL J Med Chem; 2013 Dec; 56(23):9673-82. PubMed ID: 24187998 [TBL] [Abstract][Full Text] [Related]